The role of the immune system in neurodegenerative disorders

Movement Disorders

Volumn 12, Issue 6, 1997, Pages 855-858

  McGeer, Edith G ^a   McGeer, Patrick L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID P COMPONENT; APOLIPOPROTEIN E4; C REACTIVE PROTEIN; DOPAMINE; GLUTAMIC ACID; INTERLEUKIN 6; OXYGEN RADICAL;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN DEGENERATION; COMPLEMENT SYSTEM; HUMAN; IMMUNE SYSTEM; LYMPHATIC DRAINAGE; MACROPHAGE; MICROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHORT SURVEY;

AGED; ALZHEIMER DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HLA-DR ANTIGENS; HUMANS; IMMUNE SYSTEM; MICROGLIA; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 0030687537     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120604     Document Type: Short Survey

References (15)

1. McGeer PL, McGeer EG. The inflammatory response system of the brain: Implications for therapy of Alzheimer's and other neurodegenerative diseases. Brain Res Rev 1995;21:195-218.
2. McGeer EG, McGeer PL. Neurodegeneration and the immune system. In: Calne, DB (ed). Neurodegenerative Disorders. Philadelphia: W.B. Saunders, 1994:277-300.
3. Banati RB, Gehrmann J, Schubert P. Kreutzberg GW. Cytotoxicity of microglia. Glia 1993;7:111-118.
4. McGeer EG, McGeer PL. Inflammatory cytokines in the CNS. CNS Drugs 1997;7:214-228.
5. Shen Y, Li R, McGeer EG, McGeer PL. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res (in press).
6. Akiyama H, Tooyama I, Kondo H, et al. Early response of brain resident microglia to kainic acid-induced hippocampal lesions. Brain Res 1994;635:257-268.
7. Pasinetti GM, Johnson SA, Rozovsky I, et al. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp Neurol 1992;118:117-125.
8. Yasuhara O, Kawamata T, Aimi Y, McGeer EG, McGeer PL. Expression of chromogranin A in lesions of the central nervous system from patients with neurological diseases. Neurosci Lett 1994;170:13-16.
9. Taupenot L, Ciesielski-Traska J, Ulrich G, Chasserot-Golaz S, Aunis D, Bader MF. Chromogranin A triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells. Neuroscience 1996;72:377-389.
10. McGeer PL, Schulzer M, McGeer EG. Arthritis and antiinflammatory agents as possible protective factors for Alzheimer disease: a review of seventeen epidemiological studies. Neurology 1996;47:425-432.
11. Stewart WF, Kawas C, Corrada M, Metter EJ. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997;48;626-632.
12. Bertozzi B, Barbisoni P, Franzoni S, Frisoni GB, Rozzini R, Trabucchi M. Association of chronic non-steroidal anti-inflammatory drug use and cognitive decline in non-demented elderly patients admitted to a Geriatric Evaluation and Rehabilitation Unit. Archives of Gerontology and Geriatrics 1996;23:71-79.
13. Rozzini R, Ferrucci L, Losonczy K, Havlik RJ, Guralnik JM. Protective effect of chronic NSAID use on cognitive decline in older persons. J Am Geriatr Soc 1996;44:1025-1029.
14. Rogers J, Kirby LC, Hempelman SR, et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993;43:1609-1611.
15. Breitner JCS, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease. Neurology 1994;44:227-232.